DSGN
USDDesign Therapeutics Inc. Common Stock
$6.240-0.130 (-2.041%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$6.370
High
$6.635
Low
$6.160
Volume
0.13M
Company Fundamentals
Market Cap
355.4M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.18M
Exchange
NMS
Currency
USD
52-Week Range
Low $2.6Current $6.240High $7.77
Related News
GlobeNewswire
Design Therapeutics Appoints Justin Gover to Board of Directors
CARLSBAD, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the
View more
Related Stocks
SBAC
SBA Communications Corporation
NASDAQ
Real Estate Inv...
ENVA
Enova International Inc.
NASDAQ
Finance: Consum...
RTO
Rentokil Initial plc American Depositary Shares (each representing five (5) Ordinary Shares)
NASDAQ
Other Consumer ...
CHSCL
CHS Inc Cumulative Redeemable Preferred Stock Series 4
NASDAQ
Farming/Seeds/M...
TTMI
TTM Technologies Inc.
NASDAQ
Electrical Prod...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.